Immunotherapy May Move Into Advanced Gynecologic Cancers – Curetoday.com
Curetoday.com |
Immunotherapy May Move Into Advanced Gynecologic Cancers
Curetoday.com The immunotherapy agent Opdivo (nivolumab) showed clinical acitivty in women who had recurrent/metastatic cervical cancer, and was active to a lesser extent in vaginal and vulvar cancers, according to results from the CheckMate-358 trial. BY JASON … |
